# MHPAEA Causal Inference Study ğŸ§ ğŸ“Š

## Overview ğŸŒŸ
This project investigates the causal effect of the **Mental Health Parity and Addiction Equity Act (MHPAEA)** on the utilization of mental health services and specialist consultations. The MHPAEA, enacted in 2008, mandates parity between mental health/substance use disorder (MH/SUD) benefits and medical/surgical benefits in group health plans and health insurance coverage. The focus of this study is to compare the **average treatment effect (ATE)** between individuals who received the treatment (those with private insurance) and those who did not. 

The study uses a **Difference-in-Differences (DID)** approach to estimate the causal effect, comparing pre- and post-treatment differences between the treatment and control groups. Additionally, the analysis adjusts for confounders using **propensity score matching**, ensuring more accurate comparison between groups.

## Objective ğŸ¯
- **Primary Goal**: Estimate the causal effect of MHPAEA on the utilization of mental health services by comparing the treatment group (private insurance holders) with the control group (non-private insurance holders).
- **Methodology**: 
  - **Difference-in-Differences (DID)**: To compare the pre- and post-treatment effects between the treatment and control groups.
  - **Propensity Score Matching (PSM)**: To adjust for confounding variables and make the treatment and control groups comparable.

## Data ğŸ“‘
- **Treatment Group**: Individuals with private insurance who are eligible for MHPAEA.
- **Control Group**: Individuals without private insurance who are not eligible for MHPAEA.
- **Variables**:
  - **Treatment**: Whether the individual has private insurance (treated) or not (control).
  - **Outcome**: Utilization of mental health services and specialist consultations.
  - **Covariates**: Age, gender, socioeconomic status, health conditions, etc.

## Approach ğŸ”
1. **Data Preprocessing** ğŸ§¹:
   - Clean and merge datasets containing information on insurance status, mental health service utilization, and relevant covariates.
   - Identify eligible individuals based on insurance status.

2. **Propensity Score Matching** ğŸ”„:
   - Estimate propensity scores using logistic regression or other suitable methods.
   - Match individuals in the treatment and control groups based on the estimated propensity scores to reduce bias due to confounders.

3. **Difference-in-Differences (DID)** ğŸ“‰:
   - Implement DID to estimate the effect of MHPAEA by comparing changes in utilization before and after the lawâ€™s implementation between the treatment and control groups.

4. **Statistical Analysis** ğŸ“Š:
   - Perform robustness checks and sensitivity analysis to assess the validity of the causal estimates.

## Future Work ğŸš€
- Further refine the propensity score matching method.
- Explore other potential treatment effects, such as subgroup analysis based on demographics.
- Investigate the long-term impact of MHPAEA on mental health outcomes.

/--

# MHPAEA ì¸ê³¼ì¶”ë¡  ì—°êµ¬ ğŸ§ ğŸ“Š

## ê°œìš” ğŸŒŸ
ì´ í”„ë¡œì íŠ¸ëŠ” **Mental Health Parity and Addiction Equity Act (MHPAEA)**ê°€ ì •ì‹ ê±´ê°• ì„œë¹„ìŠ¤ì™€ ì „ë¬¸ ìƒë‹´ ì´ìš©ì— ë¯¸ì¹œ ì¸ê³¼ì  ì˜í–¥ì„ ì¡°ì‚¬í•©ë‹ˆë‹¤. MHPAEAëŠ” 2008ë…„ì— ì œì •ëœ ë²•ìœ¼ë¡œ, ë¯¼ê°„ ê±´ê°• ë³´í—˜ì—ì„œ ì •ì‹ ê±´ê°•/ì•½ë¬¼ ì¤‘ë… ì¹˜ë£Œì™€ ì˜ë£Œ/ì™¸ê³¼ ì¹˜ë£Œ ê°„ì˜ í‰ë“±ì„ ë³´ì¥í•˜ë„ë¡ ìš”êµ¬í•©ë‹ˆë‹¤. ì´ ì—°êµ¬ì˜ ì´ˆì ì€ **í‰ê·  ì²˜ë¦¬ íš¨ê³¼(ATE)**ë¥¼ ë¹„êµí•˜ëŠ” ê²ƒì…ë‹ˆë‹¤. ì¦‰, ë¯¼ê°„ ë³´í—˜ ê°€ì…ì(ì¹˜ë£Œ ì§‘ë‹¨)ì™€ ë¹„ê°€ì…ì(ëŒ€ì¡° ì§‘ë‹¨) ê°„ì˜ ì •ì‹ ê±´ê°• ì„œë¹„ìŠ¤ ë° ì „ë¬¸ ìƒë‹´ ì´ìš© ì°¨ì´ë¥¼ ë¹„êµí•©ë‹ˆë‹¤.

ì´ ì—°êµ¬ëŠ” **Difference-in-Differences (DID)** ì ‘ê·¼ë²•ì„ ì‚¬ìš©í•˜ì—¬ ì¸ê³¼ì  íš¨ê³¼ë¥¼ ì¶”ì •í•˜ë©°, ì¹˜ë£Œ ì „í›„ì˜ ì°¨ì´ë¥¼ ë¹„êµí•©ë‹ˆë‹¤. ë˜í•œ **propensity score matching**ì„ ì‚¬ìš©í•˜ì—¬ í˜¼ë™ ë³€ìˆ˜ë¥¼ ì¡°ì •í•˜ê³  ë‘ ì§‘ë‹¨ì„ ë³´ë‹¤ ì •í™•í•˜ê²Œ ë¹„êµí•©ë‹ˆë‹¤.

## ëª©í‘œ ğŸ¯
- **ì£¼ìš” ëª©í‘œ**: MHPAEAê°€ ì •ì‹ ê±´ê°• ì„œë¹„ìŠ¤ ì´ìš©ì— ë¯¸ì¹œ ì¸ê³¼ì  íš¨ê³¼ë¥¼ ì¶”ì •í•˜ê¸° ìœ„í•´, ë¯¼ê°„ ë³´í—˜ ê°€ì…ì(ì¹˜ë£Œ ì§‘ë‹¨)ì™€ ë¹„ê°€ì…ì(ëŒ€ì¡° ì§‘ë‹¨) ê°„ì˜ ì°¨ì´ë¥¼ ë¹„êµí•©ë‹ˆë‹¤.
- **ë°©ë²•ë¡ **: 
  - **Difference-in-Differences (DID)**: ì¹˜ë£Œ ì „í›„ì˜ ë³€í™”ë¥¼ ë¹„êµí•˜ì—¬ ì²˜ë¦¬ íš¨ê³¼ë¥¼ ì¶”ì •í•©ë‹ˆë‹¤.
  - **Propensity Score Matching (PSM)**: í˜¼ë™ ë³€ìˆ˜ë¥¼ ì¡°ì •í•˜ì—¬ ì¹˜ë£Œ ì§‘ë‹¨ê³¼ ëŒ€ì¡° ì§‘ë‹¨ì„ ë¹„êµ ê°€ëŠ¥í•˜ê²Œ ë§Œë“­ë‹ˆë‹¤.

## ë°ì´í„° ğŸ“‘
- **ì¹˜ë£Œ ì§‘ë‹¨**: MHPAEA ì ìš© ëŒ€ìƒì¸ ë¯¼ê°„ ë³´í—˜ ê°€ì…ì.
- **ëŒ€ì¡° ì§‘ë‹¨**: MHPAEA ì ìš©ì„ ë°›ì§€ ì•ŠëŠ” ë¹„ë³´í—˜ ê°€ì…ì.
- **ë³€ìˆ˜**:
  - **ì²˜ì¹˜**: ë¯¼ê°„ ë³´í—˜ ê°€ì… ì—¬ë¶€ (ì¹˜ë£Œ ì§‘ë‹¨: ì²˜ì¹˜, ëŒ€ì¡° ì§‘ë‹¨: ëŒ€ì¡° ì§‘ë‹¨).
  - **ê²°ê³¼**: ì •ì‹ ê±´ê°• ì„œë¹„ìŠ¤ ë° ì „ë¬¸ ìƒë‹´ ì´ìš© ì—¬ë¶€.
  - **ê³µë³€ëŸ‰**: ë‚˜ì´, ì„±ë³„, ì‚¬íšŒê²½ì œì  ìƒíƒœ, ê±´ê°• ìƒíƒœ ë“±.

## ì ‘ê·¼ë²• ğŸ”
1. **ë°ì´í„° ì „ì²˜ë¦¬** ğŸ§¹:
   - ë³´í—˜ ìƒíƒœ, ì •ì‹ ê±´ê°• ì„œë¹„ìŠ¤ ì´ìš© ì •ë³´ ë° ê´€ë ¨ ê³µë³€ëŸ‰ì„ í¬í•¨í•œ ë°ì´í„° ì •ë¦¬ ë° ë³‘í•©.
   - ë³´í—˜ ê°€ì… ì—¬ë¶€ì— ë”°ë¼ ì—°êµ¬ ëŒ€ìƒì ì„ ì •.

2. **Propensity Score Matching** ğŸ”„:
   - ë¡œì§€ìŠ¤í‹± íšŒê·€ ë“±ì˜ ë°©ë²•ìœ¼ë¡œ propensity score ì¶”ì •.
   - ì¶”ì •ëœ propensity scoreë¥¼ ë°”íƒ•ìœ¼ë¡œ ì¹˜ë£Œ ì§‘ë‹¨ê³¼ ëŒ€ì¡° ì§‘ë‹¨ì„ ë§¤ì¹­í•˜ì—¬ í˜¼ë™ ë³€ìˆ˜ì˜ ì˜í–¥ì„ ìµœì†Œí™”.

3. **Difference-in-Differences (DID)** ğŸ“‰:
   - DID ë°©ë²•ì„ ì ìš©í•˜ì—¬ MHPAEA ë²•ì•ˆ ì‹œí–‰ ì „í›„ì˜ ì´ìš© ë³€í™”ëŸ‰ì„ ë¹„êµí•˜ì—¬ ì²˜ë¦¬ íš¨ê³¼ ì¶”ì •.

4. **í†µê³„ ë¶„ì„** ğŸ“Š:
   - ì¸ê³¼ ì¶”ì •ì˜ ìœ íš¨ì„±ì„ ê²€í† í•˜ê¸° ìœ„í•œ ê°•ê±´ì„± ê²€ì • ë° ë¯¼ê°ë„ ë¶„ì„ ìˆ˜í–‰.

## í–¥í›„ ì‘ì—… ğŸš€
- Propensity score matching ë°©ë²• ê°œì„ .
- ì¸êµ¬í†µê³„í•™ì  ë³€ìˆ˜ì— ë”°ë¥¸ í•˜ìœ„ ê·¸ë£¹ ë¶„ì„ ë“± ë‹¤ë¥¸ ì²˜ë¦¬ íš¨ê³¼ íƒìƒ‰.
- MHPAEAì˜ ì •ì‹ ê±´ê°• ê²°ê³¼ì— ëŒ€í•œ ì¥ê¸°ì  ì˜í–¥ ë¶„ì„.
